Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA delay
Biotech
Regenxbio's Hunter gene therapy latest to face FDA delay
The review extension and request for more data bears the fingerprints of recently returned CBER head Vinay Prasad, M.D.
Darren Incorvaia
Aug 19, 2025 10:30am
Another biotech hit with FDA delay for ALS asset
Aug 18, 2025 11:01am
FDA delays decision on Biohaven troriluzole filing, plans adcomm
May 15, 2025 6:02am
FDA misses PDUFA date for Stealth’s ultra-rare disease candidate
Apr 30, 2025 9:00am
FDA delays decision on Merus' first-in-class cancer drug
Nov 5, 2024 9:14am
FDA demands data on 2 PTC candidates, delaying filing
Oct 27, 2023 7:30am